Amgen Inc. (AMGN)

Basic

  • Market Cap

    $145.81B

  • EV

    $171.54B

  • Shares Out

    535.18M

  • Revenue

    $26.83B

  • Employees

    25,200

Margins

  • Gross

    73.73%

  • EBITDA

    49.57%

  • Operating

    36.15%

  • Pre-Tax

    32.61%

  • Net

    28.2%

  • FCF

    34.95%

Returns (5Yr Avg)

  • ROA

    9.51%

  • ROE

    78.2%

  • ROCE

    18.93%

  • ROIC

    20.89%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $276.06

  • P/E

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

Per Share

  • Rev

    $50.16

  • Earnings (Dil)

    $14.06

  • FCF

    $17.43

  • Book Value

    $14.31

Growth (CAGR)

  • Rev 3Yr

    2.4%

  • Rev 5Yr

    2.85%

  • Rev 10Yr

    4.09%

  • Dil EPS 3Yr

    4.28%

  • Dil EPS 5Yr

    34.39%

  • Dil EPS 10Yr

    8.35%

  • Rev Fwd 2Yr

    10.93%

  • EBITDA Fwd 2Yr

    5.25%

  • EPS Fwd 2Yr

    6.06%

  • EPS LT Growth Est

    5.85%

Dividends

  • Yield

  • Payout

    58.9%

  • DPS

    $8.33

  • DPS Growth 3Yr

    10.05%

  • DPS Growth 5Yr

    10.27%

  • DPS Growth 10Yr

    16.75%

  • DPS Growth Fwd 2Yr

    9.52%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM

Revenues

22,533.0

22,204.0

24,240.0

24,297.0

24,801.0

25,629.0

Other Revenues, Total

1,214.0

1,158.0

1,184.0

1,682.0

1,522.0

1,204.0

Total Revenues

23,747.0

23,362.0

25,424.0

25,979.0

26,323.0

26,833.0

Total Revenues % Chg.

3.9%

-1.6%

8.8%

2.2%

1.3%

1.9%

Cost of Goods Sold, Total

4,101.0

4,356.0

6,159.0

6,454.0

6,406.0

7,050.0

Gross Profit

19,646.0

19,006.0

19,265.0

19,525.0

19,917.0

19,783.0

Selling General & Admin Expenses, Total

5,332.0

5,150.0

5,730.0

5,368.0

5,414.0

5,464.0

R&D Expenses

3,737.0

4,116.0

4,207.0

4,819.0

4,434.0

4,557.0

Other Operating Expenses

26.0

63.0

Other Operating Expenses, Total

9,095.0

9,266.0

9,937.0

10,187.0

9,848.0

10,084.0

Operating Income

10,551.0

9,740.0

9,328.0

9,338.0

10,069.0

9,699.0

Interest Expense, Total

-1,392.0

-1,289.0

-998.0

-1,197.0

-1,406.0

-2,469.0

Interest And Investment Income

1,200.0

Net Interest Expenses

-192.0

-1,289.0

-998.0

-1,197.0

-1,406.0

-2,469.0

Income (Loss) On Equity Invest.

292.0

Currency Exchange Gains (Loss)

-241.0

110.0

323.0

-245.0

-233.0

171.0

Other Non Operating Income (Expenses)

587.0

-26.0

978.0

-180.0

795.0

EBT, Excl. Unusual Items

10,118.0

9,148.0

8,627.0

8,874.0

8,250.0

8,488.0

Restructuring Charges

-66.0

-194.0

-252.0

Merger & Related Restructuring Charges

Gain (Loss) On Sale Of Investments

-117.0

56.0

-305.0

-474.0

-479.0

846.0

Gain (Loss) On Sale Of Assets

-503.0

62.0

Asset Writedown

-330.0

-783.0

In Process R&D Expenses

-1,505.0

Legal Settlements

-189.0

Other Unusual Items

-126.0

78.0

390.0

EBT, Incl. Unusual Items

9,545.0

9,138.0

8,133.0

6,701.0

7,346.0

8,751.0

Income Tax Expense

1,151.0

1,296.0

869.0

808.0

794.0

1,185.0

Earnings From Continuing Operations

8,394.0

7,842.0

7,264.0

5,893.0

6,552.0

7,566.0

Net Income

8,394.0

7,842.0

7,264.0

5,893.0

6,552.0

7,566.0

Net Income to Common Incl Extra Items

8,394.0

7,842.0

7,264.0

5,893.0

6,552.0

7,566.0

Net Income to Common Excl. Extra Items

8,394.0

7,842.0

7,264.0

5,893.0

6,552.0

7,566.0

Total Shares Outstanding

629.6

591.4

578.3

558.3

534.0

535.1

Weighted Avg. Shares Outstanding

661.0

605.0

586.0

570.0

538.0

535.0

Weighted Avg. Shares Outstanding Dil

665.0

609.0

590.0

573.0

541.0

538.0

EPS

12.7

13.0

12.4

10.3

12.2

14.1

EPS Diluted

12.6

12.9

12.3

10.3

12.1

14.1

EBITDA

12,481.0

11,775.0

12,929.0

12,736.0

13,486.0

13,301.0